Standard BioTools Inc. (LAB)
NASDAQ: LAB · Real-Time Price · USD
1.130
-0.020 (-1.74%)
Apr 16, 2025, 10:06 AM EDT - Market open
Standard BioTools Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Standard BioTools stock has a target of 2.50, which predicts an increase of 121.24% from the current stock price of 1.13.
Analyst Consensus: Buy
* Price targets were last updated on Oct 31, 2024.
Analyst Ratings
The average analyst rating for Standard BioTools stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 3 | 3 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Keybanc | Keybanc | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Feb 27, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $2.75 → $2.5 | Strong Buy | Maintains | $2.75 → $2.5 | +121.24% | Oct 31, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $3.5 → $2.75 | Strong Buy | Maintains | $3.5 → $2.75 | +143.36% | Aug 1, 2024 |
| TD Cowen | TD Cowen | Strong Buy Initiates $3.5 | Strong Buy | Initiates | $3.5 | +209.73% | Apr 16, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $3.25 | Strong Buy | Initiates | $3.25 | +187.61% | Apr 4, 2024 |
Financial Forecast
Revenue This Year
170.89M
from 174.43M
Decreased by -2.03%
Revenue Next Year
192.71M
from 170.89M
Increased by 12.77%
EPS This Year
-0.26
from -0.52
EPS Next Year
-0.17
from -0.26
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 180.4M | 206.9M | 218.3M | |
| Avg | 170.9M | 192.7M | 210.0M | |
| Low | 162.2M | 182.0M | 203.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 3.4% | 21.0% | 13.3% | |
| Avg | -2.0% | 12.8% | 9.0% | |
| Low | -7.0% | 6.5% | 5.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.21 | -0.08 | -0.04 |
| Avg | -0.26 | -0.17 | -0.04 |
| Low | -0.31 | -0.25 | -0.04 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.